Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Blood
|
November 9, 2007
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma
Ruben Niesvizky, David S Jayabalan, Paul J Christos, et al.
Cancers
|
October 13, 2021
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group
Mieke R Van Bockstal, Maxine Cooks, Iris Nederlof, et al.
Sensors (Basel, Switzerland)
|
January 11, 2022
The SALT-Readout ASIC for Silicon Strip Sensors of Upstream Tracker in the Upgraded LHCb Experiment
Carlos Abellan Beteta, Dimitra Andreou, Marina Artuso, et al.
The Journal of Pathology
|
March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
The Journal of Pathology
|
August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
David B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Blood
|
November 9, 2007
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma
Ruben Niesvizky, David S Jayabalan, Paul J Christos, et al.
Cancers
|
October 13, 2021
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group
Mieke R Van Bockstal, Maxine Cooks, Iris Nederlof, et al.
Sensors (Basel, Switzerland)
|
January 11, 2022
The SALT-Readout ASIC for Silicon Strip Sensors of Upstream Tracker in the Upgraded LHCb Experiment
Carlos Abellan Beteta, Dimitra Andreou, Marina Artuso, et al.
The Journal of Pathology
|
March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
The Journal of Pathology
|
August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
David B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
Page
of 5